Clinical trial · Interventional
Exercise Post-Diagnosis of Breast Cancer
A Pilot Study: The Effect of Longitudinal Exercise Programming in Breast Cancer Patients
NCT04013568CI-TRIAL-00106866completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators are doing this study to determine if there are body composition changes after a 12-week exercise program in breast cancer patients and determine what factors contribute to sustained physical activity after the 12-week exercise program intervention.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Exercise | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Group 1 - Agree to Exercise Program
- description
- 12-week exercise program
- interventionNames
- Other: Exercise
- type
- NO_INTERVENTION
- label
- Group 2 - Declines Exercise Program
- description
- Same biometric and biomarker assessment at as Group 1 (at baseline, after 12 weeks and annually) however they will not participate in the exercise sessions
Primary outcomes (11)
- measure
- Fat mass
- timeFrame
- 1 day
- description
- Measure fat mass (arms, legs, trunk and total) in kg using Dual energy X-ray absorptiometry (DXA) data
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * New diagnosis of breast cancer (within the past 2 years, any subtype, stage I-III) * Can be undergoing neo/adjuvant treatment (surgery, chemotherapy, radiation or endocrine therapy) * Participant is willing and able to comply with the protocol for the duration of the study including undergoing scheduled exercise sessions, completing questionnaires and biometric/biomarker studies * Participant must be able to lie flat on their back for up to 10 minutes * Participant must be able to stand without aid for at least 2 minutes Exclusion Criteria: * Participant with breast cancer recurrence * Metastatic breast cancer * Uncontrolled psychiatric disorder that can affect self-assessment * Pregnant patient * Participants with any internal artifact (e.g. pacemakers, internal fixation, arthroplasty) or other physical impairment that would alter the body composition assessment
References
Publications (0)
Data not yet available
No reference posted for this study.